16292 Dupilumab treatment for up to 3 years demonstrates sustained efficacy in adult patients with moderate to severe atopic dermatitis: Results from LIBERTY AD Adult OLE
Blauvelt, Andrew, Hussain, Iftikhar, Beazley, Bethany A., Patel, Naimish, Genzyme, Sanofi, Ruddy, Marcella, Staudinger, Heribert, Graham, Neil M.H., BradShumel
Published in Journal of the American Academy of Dermatology (01.12.2020)
Published in Journal of the American Academy of Dermatology (01.12.2020)
Get full text
Journal Article
15108 Long-term efficacy and safety of dupilumab in adolescents with atopic dermatitis: Results from an open-label extension trial (LIBERTY AD PED-OLE)
Blauvelt, Andrew, Guttman, Emma, Hussain, Iftikhar, Chen, Zhen, Mina-Osorio, Paola, Rossi, Ana Beatris, Genzyme, Sanofi, Bansal, Ashish
Published in Journal of the American Academy of Dermatology (01.12.2020)
Published in Journal of the American Academy of Dermatology (01.12.2020)
Get full text
Journal Article
Sanofi Initiates Phase 2 Clinical Trial to Evaluate Parkinson's Therapy
Get full text
Trade Publication Article